On Mar 14, 2022 Nutcracker Therapeutics closed a Series C round and raised $167,000,000 from ARCH Venture Partners, featuring lead investors ARCH Venture Partners. About […]
Series B – Medilink Therapeutics
On Mar 14, 2022 Medilink Therapeutics closed a Series B round and raised $70,000,000 from Highlight Capital, Legend Capital, Loyal Valley Capital, LYFE Capital, Qiming […]
Post-IPO Equity – Agile Therapeutics
On Mar 14, 2022 Agile Therapeutics closed a Post-IPO Equity round and raised $4,850,000 from investors, featuring lead investors . About the company: Agile Therapeutics […]
Series C – Nutcracker Therapeutics
On Mar 14, 2022 Nutcracker Therapeutics closed a Series C round and raised $167,000,000 from ARCH Venture Partners, featuring lead investors ARCH Venture Partners. About […]
Post-IPO Equity – FluoGuide
On Mar 10, 2022 FluoGuide closed a Post-IPO Equity round and raised SEK250,000,000 from investors, featuring lead investors . About the company: FluoGuide is located […]
Post-IPO Equity – Freeline
On Mar 10, 2022 Freeline closed a Post-IPO Equity round and raised $26,100,000 from Syncona Partners LLP, featuring lead investors Syncona Partners LLP. About the […]
Post-IPO Equity – Puma Biotechnology
On Mar 10, 2022 Puma Biotechnology closed a Post-IPO Equity round and raised $10,000,000 from Alan H. Auerbach, Athyrium Capital Management LP, featuring lead investors […]
Seed Round – Maxwell Biosciences
On Mar 10, 2022 Maxwell Biosciences closed a Seed round and raised $10,800,000 from DecentraNet, Joseph Ventures, Keiretsu Forum, Star Lake Bioventures, featuring lead investors […]
Series A – Scenic Biotech
On Mar 10, 2022 Scenic Biotech closed a Series A round and raised €28,000,000 from BioGeneration Ventures, BioMedPartners, EIR Ventures, INKEF Capital, Oxford Science Enterprises, […]
Post-IPO Equity – FluoGuide
On Mar 10, 2022 FluoGuide closed a Post-IPO Equity round and raised SEK250,000,000 from investors, featuring lead investors . About the company: FluoGuide is located […]
